Buy Ionis (IONS): Antisense Momentum and a Clear Trade Plan Into Sector Re-rating
Ionis offers concentrated exposure to the antisense oligonucleotide boom. Recent sector news — including strong early-stage data from peers and bullish market forecasts — increases the odds of a valuation re-rate. With a market cap near $12.7B and clear technical momentum, we recommend a long trade: entry $77.00, target $95.00, stop $66.00, horizon…